CD8A and hepatocellular carcinoma: APCs present neoantigens to the T‐cell receptor (TCR) of CD8+ cytotoxic T lymphocytes via MHC class I molecules, leading to the activation of T cells that subsequently infiltrate the HCC tissue.79